Yinhan Zhou

Statistics

Publications

Citations

302

H-Index

Active since

2022

Affiliations

Denali Therapeutics (United States)(Current)

Ionis Pharmaceuticals (United States)

Yinhan Zhou is an author at Denali Therapeutics (United States) specializing in targeted delivery across the blood-brain barrier, brain targeted delivery, and drug delivery.

Publications per year

2022–2025

Publications

Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier

Scarlett J. Barker, Mai B. Thayer, Chaeyoung Kim et al. · Science Translational Medicine · 2024 · 119 citations

Pharmacy, Neuroscience, Pharmacology +17

CD98hc is a target for brain delivery of biotherapeutics

Kylie S. Chew, Robert C. Wells, Arash Moshkforoush et al. · Nature Communications · 2023 · 88 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Fc-engineered large molecules targeting blood-brain barrier transferrin receptor and CD98hc have distinct central nervous system and peripheral biodistribution

Nathalie Khoury, Michelle E. Pizzo, Claire B. Discenza et al. · Nature Communications · 2025 · 50 citations · Full text

Pharmacy, Neuroscience, Pharmaceutics +16

Targeting Transferrin Receptor to Transport Antisense Oligonucleotides Across the Blood-Brain Barrier

Scarlett J. Barker, Mai B. Thayer, Chaeyoung Kim et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2023 · 24 citations · Full text

Pharmacy, Neuroscience, Pharmaceutics +17

Humanization of a strategic CD3 epitope enables evaluation of clinical T-cell engagers in a fully immunocompetent in vivo model

Julie A. Zorn, Matthew L. Wheeler, Ralston M. Barnes et al. · Scientific Reports · 2022 · 21 citations · Full text

Life Sciences, Immunology, Oncology +14

1–5 of 5